Filing Details
- Accession Number:
- 0001214659-20-007348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-18 18:52:10
- Reporting Period:
- 2020-08-17
- Accepted Time:
- 2020-08-18 18:52:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1753840 | Mark Daniels | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-17 | 20,994 | $5.95 | 74,712 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-08-17 | 5,994 | $67.00 | 68,718 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-17 | 7,500 | $68.00 | 61,218 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-17 | 7,500 | $69.00 | 53,718 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-08-17 | 20,994 | $0.00 | 20,994 | $5.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,878 | 2026-08-29 | No | 4 | M | Direct |
Footnotes
- The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.